Cargando…
Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734040/ https://www.ncbi.nlm.nih.gov/pubmed/33328769 http://dx.doi.org/10.2147/CPAA.S289793 |
| _version_ | 1783622387592331264 |
|---|---|
| author | Liao, Michael Z Kast, Johannes Berkhout, Marloes Prenen, Hans Dutta, Sandeep Upreti, Vijay V |
| author_facet | Liao, Michael Z Kast, Johannes Berkhout, Marloes Prenen, Hans Dutta, Sandeep Upreti, Vijay V |
| author_sort | Liao, Michael Z |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7734040 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77340402020-12-15 Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter] Liao, Michael Z Kast, Johannes Berkhout, Marloes Prenen, Hans Dutta, Sandeep Upreti, Vijay V Clin Pharmacol Response to Letter Dove 2020-12-09 /pmc/articles/PMC7734040/ /pubmed/33328769 http://dx.doi.org/10.2147/CPAA.S289793 Text en © 2020 Liao et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Response to Letter Liao, Michael Z Kast, Johannes Berkhout, Marloes Prenen, Hans Dutta, Sandeep Upreti, Vijay V Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter] |
| title | Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter] |
| title_full | Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter] |
| title_fullStr | Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter] |
| title_full_unstemmed | Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter] |
| title_short | Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter] |
| title_sort | is bodyweight-based dosing truly better than flat dosing for panitumumab? [response to letter] |
| topic | Response to Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734040/ https://www.ncbi.nlm.nih.gov/pubmed/33328769 http://dx.doi.org/10.2147/CPAA.S289793 |
| work_keys_str_mv | AT liaomichaelz isbodyweightbaseddosingtrulybetterthanflatdosingforpanitumumabresponsetoletter AT kastjohannes isbodyweightbaseddosingtrulybetterthanflatdosingforpanitumumabresponsetoletter AT berkhoutmarloes isbodyweightbaseddosingtrulybetterthanflatdosingforpanitumumabresponsetoletter AT prenenhans isbodyweightbaseddosingtrulybetterthanflatdosingforpanitumumabresponsetoletter AT duttasandeep isbodyweightbaseddosingtrulybetterthanflatdosingforpanitumumabresponsetoletter AT upretivijayv isbodyweightbaseddosingtrulybetterthanflatdosingforpanitumumabresponsetoletter |